Theme: An attempt for a Gynecologic Cancer free era

Gynecologic Cancer 2017

Gynecologic Cancer 2017

About Conference

Gynecologic Cancers Congress 

Dates: August 28-29, 2017

Venue: London, UK

Gynecologic Cancers 2017 conference will be host by Conference Series LLC  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

Conference Series LLC is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

Conference Series LLC organising a wide range of Cancer ConferencesCancer meetingsGlobal Cancer Conferences, Surgical Oncology, like Skin cancer conferences, Breast Cancer Conferences, Liver Cancer Conferences, Gynecology Cancer Conferences, Lung Cancer meetings and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend Gynecologic Cancers 2017?

With members from around the world focused on learning about Gynecologic Cancer this is best opportunity to reach the largest assemblage of participants from the world like as: societies, universities, research groups, scientists, researchers, PhD scholars, who will Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in  Gynecologic Cancer conference are the hallmarks of this conference.

Target Audience

·         Oncologists

·         Gynaecologists

·         Radiologists

·         Pathologists

·         Scientists

·         Students

·         Researchers

·         Faculty

·         Gynecology Cancer Associations and Societies

·         Business Entrepreneurs

·         Training Institutes

·         Pharmaceutical Companies

·         Medical Devices Companies

·         Data Management Companies

 

 





Sessions/Tracks

Conference Series LLC invites all the participants across the globe to attend ‘International Congress on Contemporary Issues in Women's Cancers and Gynecologic Oncology’ August 28-29, 2017, at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Conference Series LLC, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

With members from around the world focused on learning about Cancers; this is your best opportunity to reach the largest assemblage of participants from the The International Gynecologic Cancer Society  European Cervical Cancer Association,  International Papillomavirus Society , American Society for Colposcopy and Cervical PathologyThe British Gynaecological Cancer Society International Federation for Cervical Pathology and Colposcopy . Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Gynecologic Cancers are hallmarks of this conference.

This Gynecologic Cancers conference will have two days of discussions on methods and strategies related to management, quality improvement of  Cancer as well as to explore the new ideas and concepts on global scale and the topics include Uterine CancerVaginal CancerOvarian CancerHPV related cancer. Gynecologic Cancer 2017 will mainly focus on the Cause of the cancer and its Symptoms, Prognosis, Types,  Stages, Tests, Clinical trials to screen for Gynecologic Cancers, Diagnosis and Treatment, Early detection and Prevention, Vaccine, Latest Research, Case Report.

Track 1: Women Cancer

Cancers that originates in the female reproductive part is known as women cancer or Gynecologic Cancer. The women cancer includes cervical cancer, ovarian cancer, breast cancer, endometrial/uterine cancer, vaginal/ vulva cancer. Gynecologic cancer is unique, with different signs and symptoms, different risk factors, and different prevention strategies. All women are at risk for Gynecologic cancers, and risk increases with age. When Gynecologic cancers are found early, treatment is most effective.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

19th World Cancer Conference, November 21-23, 2017 London, UK; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain;  Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 2:  Gynecology Oncology

Gynecologic oncology is a specify field of medicine that emphases on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers. A Gynecologic oncologist is a gynaecologist who specializes in the diagnosis and treatment of women with cancer of the reproductive organs. Specifically, the gynecologic oncologist treats cancer of the ovary, endometrium, uterus, cervix, vagina, vulva and trophoblastic disease.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;  

Track 3: Cervical Cancer

Cervical Cancer is one of the most common cancers in women worldwide. But in the United States and other countries where cervical cancer screening is routine, this cancer is not so common. Most cervical cancer is caused by a virus called Human papillomavirus, or HPV. There are many types of the HPV virus. Not all types of HPV cause cervical cancer. Some of them cause genital warts, but other types may not show any Cervical Cancer symptoms and signs. An infection may go away on its own. But sometimes it can cause genital warts or lead to cervical cancer. That's why it's important for women to have regular Pap tests. A Pap test can find changes in cervical cells before they turn into cancer cells. If you treat these cell changes, you may prevent cervical cancer.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; ESMO 2017 Congress, September 8-12, 2017, Spain;  European Lung Cancer Conference, May 5-8,2017,Switzerland; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 18th  World Conference on Lung Cancer October 15 - 18 2017 | Yokohama, Japan; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; Preventive oncology  July 20-21, 2017 Chicago, USA

Track 4: Ovarian Cancer

Ovarian cancer when cancer starts in the ovaries, it is called ovarian cancer. Women have two ovaries that are located in the pelvis, one on each side of the uterus. The ovaries make female hormones and produce eggs.Ovarian cancer causes more deaths than any other cancer of the female reproductive system. Ovarian cancer often causes signs and symptoms, so it is important to pay attention to your body and know what is normal for you.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

3rd Urologic Oncology Conference June 26-28, 2017 Baltimore, USA; 19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; ESMO 2017 Congress, September 8-12, 2017, Spain;  European Lung Cancer Conference, May 5-8,2017,Switzerland; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 18th  World Conference on Lung Cancer October 15 - 18 2017 | Yokohama, Japan; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; Preventive oncology  July 20-21, 2017 Chicago, USA ;

Track 5Endometrial Cancer

Endometrial cancer or uterine cancer when cancer starts in the uterus, it is called uterine cancer. The uterus is the pear-shaped organ in a woman’s pelvis . The uterus, also called the womb, is where the baby grows when a woman is pregnant. The most common type of uterine cancer is also called endometrial cancer because it forms in the lining of uterus, called the endometrium. When uterine cancer is found early, treatment works best.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

3rd Urologic Oncology Conference June 26-28, 2017 Baltimore, USA; 19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; ESMO 2017 Congress, September 8-12, 2017, Spain;  European Lung Cancer Conference, May 5-8,2017,Switzerland; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 18th  World Conference on Lung Cancer October 15 - 18 2017 | Yokohama, Japan; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; Preventive oncology  July 20-21, 2017 Chicago, USA ;

Track 6: Vaginal Cancer/Vulvar Cancer

Vaginal cancer when cancer starts in the vagina, it is called vaginal cancer. The vagina, also called the birth canal, is the hollow, tube-like channel between the bottom of the uterus and the outside of the body.

Vulvar cancer when cancer starts in the vulva, it is called vulvar cancer. The vulva is the outer part of the female genital organs. It has two folds of skin, called the labia. Vulvar cancer most often occurs on the inner edges of the labia.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;  

Track 7: Breast Cancer

Breast cancer starts when cells in the breast begin to grow out of control. These cells usually form a tumor that can often be seen on an x-ray or felt as a lump. The tumor is malignant (cancerous) if the cells can grow into (invade) surrounding tissues or spread to distant areas of the body. Breast cancer occurs almost entirely in women, but men can get it, too. Although many types of breast cancer can cause a lump in the breast, not all do. There are other symptoms of breast cancer you should watch out for and report to a health care provider.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

Preventive oncology  July 20-21, 2017 Chicago, USA;19th World Cancer Conference, November 21-23, 2017 London, UK; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain;  Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 8: Gynecologic Cancers: Signs and Symptoms

Women with early cervical cancers and pre-cancers usually have no symptoms. Symptoms often do not begin until a pre-cancer becomes a true invasive cancer and grows into nearby tissue. When this happens, the most common symptoms are: Abnormal vaginal bleeding, such as bleeding after sex (vaginal intercourse), bleeding after menopause, bleeding and spotting between periods, and having longer or heavier (menstrual) periods than usual. Bleeding after douching, or after a pelvic exam is a common symptom of cervical cancer but not pre-cancer. An unusual discharge from the vagina − the discharge may contain some blood and may occur between your periods or after menopause; Pain during sex (vaginal intercourse).

Ovarian cancer may cause several signs and symptoms. The most common symptoms include

Bloating

Pelvic or abdominal pain

Trouble eating or feeling full quickly

Urinary symptoms such as urgency or frequency

These symptoms are also commonly caused by benign (non-cancerous) diseases and by cancers of other organs. If a woman has these symptoms more than 12 times a month, she should see her doctor, preferably a gynaecologist.

Others symptoms of ovarian cancer can include:

Fatigue, Upset stomach, Back pain, Pain during sex, Constipation, Menstrual changes, Abdominal swelling with weight loss

Endometrial cancer Signs and Symptoms

The symptoms may include vaginal bleeding, such as a change in their periods or bleeding between periods or after menopause. This symptom can also occur with some non-cancerous conditions, but it is important to have a test. If you have gone through menopause already, it’s especially important to report any vaginal bleeding, spotting, or abnormal discharge to your doctor.

Pain in the pelvis, feeling a mass, and losing weight without trying can also be symptoms of endometrial cancer.

Vaginal cancer Signs and Symptoms

The may include

Abnormal vaginal bleeding (often after intercourse)

Abnormal vaginal discharge

A mass that can be felt

Pain during intercourse

Having these symptoms does not always mean that you have cancer. In fact, these symptoms are more likely to be caused by something besides cancer, like an infection. The only way to know for sure what’s causing these problems is to see a health care professional.

Vulva cancer Signs and Symptoms

Women with vulvar cancer may experience the following symptoms or signs. Sometimes, women with vulvar cancer do not show any of these symptoms.

A lump or growth in or on the vulvar area

A patch of skin that is differently textured or colored than the rest of the vulvar area

Persistent itching, pain, soreness, or burning in the vulvar area

Painful urination

Bleeding or discharge that is not menstrual blood

An ulcer that persists for more than one month

Breast Cancer Signs and Symptoms

The first symptoms of breast cancer are usually an area of thickened tissue in the woman's breast, or a lump. The majority of lumps are not cancerous; however, women should get them checked by a health care professional.

The symptoms includes

A lump in a breast

A pain in the armpits or breast that does not seem to be related to the woman's menstrual period

Pitting or redness of the skin of the breast; like the skin of an orange

  A rash around (or on) one of the nipples

  A swelling (lump) in one of the armpits

 An area of thickened tissue in a breast

 One of the nipples has a discharge; sometimes it may contain blood

  The nipple changes in appearance; it may become sunken or inverted

  The size or the shape of the breast changes

  The nipple-skin or breast-skin may have started to peel, scale or flake.

 

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

Preventive oncology  July 20-21, 2017 Chicago, USA;19th World Cancer Conference, November 21-23, 2017 London, UK; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain;  Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 9: Gynecologic Cancer: Treatment and Monitoring

Surgery

Surgery is the removal of the tumor and surrounding tissue during an operation. A surgical oncologist is a doctor who specializes in treating cancer using surgery. A hysterectomy is the removal of the uterus and cervix. Hysterectomy can be either a simple hysterectomy, which is the removal of the uterus and cervix, or a radical hysterectomy which is the removal of the uterus, cervix, upper vagina, and the tissue around the cervix.

Radiation therapy

Radiation therapy is the use of high-energy x-rays or other particles to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a Radiation Oncologist. Radiation therapy may be given alone, before surgery, or instead of surgery to shrink the tumor. Many women may be treated with a combination of radiation therapy and chemotherapy.

Chemotherapy

Chemotherapy is the use of drugs to destroy cancer cells, usually by stopping the cancer cells ability to grow and divide. Chemotherapy is given by a medical oncologist, a doctor who specializes in treating cancer with medication. Systemic chemotherapy is delivered through the bloodstream to reach cancer cells throughout the body. Common ways to give chemotherapy include an intravenous (IV) tube placed into a vein using a needle or in a pill or capsule that is swallowed (orally).

Immunotherapy

Another avenue of immunotherapy for Gynecologic and cervical cancers is adoptive T cell transfer. In this approach, T cells are removed from a patient, genetically modified or treated with chemicals to enhance their activity, and then re-introduced into the patient with the goal of improving the T cell immune system’s anti-cancer response.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

19th World Cancer Conference, November 21-23, 2017 London, UK; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain;  Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 10:Human papilloma Virus

HPV is consists of more than 150 related viruses. Some HPV types can causes cancer, especially cervical cancer. There are more than 40 HPV types that can infect the genital areas of males and females. But there are vaccines that can prevent infection with the most common types of HPV. HPV can transmit by having vaginal, anal, or oral sex with someone who has the virus. It is most commonly spread during vaginal or anal sex.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

19th World Cancer Conference, November 21-23, 2017 London, UK; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain;  Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 11: HPV Vaccines

There are three vaccines which are approved by the FDA to prevent HPV infection: Gardasil, Gardasil 9, and Cervarix. All three vaccines prevent infections with HPV types 16 and 18, two high-risk HPV that cause 70% of cervical cancers and an even higher percentage of some of the other HPV-associated cancer. Gardasil also prevents infection with HPV types 6 and 11, which cause 90% of genital warts.

How effective are HPV vaccinesHPV vaccines are highly effective in preventing infection with the HPV they target when given before initial exposure to the virus—which means before individuals begin to engage in sexual activity. In the trials that led to approval of Gardasil and Cervarix, these vaccines were found to provide nearly 100% protection against persistent cervical infections with HPV types 16 and 18 and the cervical cell changes that these persistent infections can cause.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; ESMO 2017 Congress, September 8-12, 2017, Spain;  Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 12: Women Health

Women have distinctive health issues. And some of the health issues are affect both men and women can affect women differently.

Distinctive issues include pregnancy, menopause, and conditions of the female organs. Women can have a healthy pregnancy by getting early and regular prenatal care. They should also get recommended breast cancer, cervical cancer, and bone density screenings. Women and men also have many of the same health problems. But these problems can affect women differently. For example,

Women are more likely to die following a heart attack than men, women are more likely to show signs of depression and anxiety than men, the effects of sexually transmitted diseases can be more serious in women, Osteoarthritis affects more women than men, Women are more likely to have urinary tract problems etc.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; ESMO 2017 Congress, September 8-12, 2017, Spain; Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA;

Track 13: Gynecologic Cancer: Surgical Methods

Surgery is most often used to treat very early cancers.

Debulking epithelial ovarian cancer

The other important goal of surgery is to remove as much of the tumor as possible − this is called debulking. Debulking is very important in any patient with ovarian cancer that has already spread widely throughout the abdomen at the time of surgery.

Sometimes the surgeon will need to remove a piece of colon to debulk the cancer properly. In some cases, a piece of colon is removed and then the 2 ends that remain are sewn back together. In other cases, though, the ends can’t be sewn back together right away. Instead, the top end of the colon is attached to an opening in the skin of the abdomen to allow body wastes to get out.

Cryosurgery

A metal probe cooled with liquid nitrogen is put in the vagina and on the cervix. This kills the abnormal cells by freezing them. Cryosurgery is used to treat stage 0 cancers (carcinoma in situ), but it is not used for invasive cancer.

Laser surgery

A laser beam is used to burn off cells or to remove a small piece of tissue for study. Laser surgery is used for stage 0 cancers (carcinoma in situ), but it is not used for invasive cancer.

Hysterectomy

In a hysterectomy, the uterus and cervix are removed. The ovaries and fallopian tubes or pelvic lymph nodes may be taken out during the same operation, but this isn't a part of every hysterectomy. Some very early stage-I cervical cancers are treated with a hysterectomy. A hysterectomy is also used for some stage 0 cancers if the cone biopsy didn’t remove all the cancer. In Radical hysterectomy the surgeon removes more than just the uterus.

Trachelectomy

A procedure called a radical trachelectomy lets certain young women with early stage cervical cancer is treated without losing their ability to have children. This method takes out the cervix and the upper part of the vagina but leaves the body of the uterus behind. The doctor puts in a "purse-string" stitch to act as an opening of the cervix inside the uterus.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; 8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;  

Track 14:  Gynecologic Cancer: Screening and Diagnosis

The following procedures may be used:

Physical Exam and History: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patient health habits and past illnesses and treatments will also be taken.

Pap Test: A procedure to collect cells from the surface of the cervix and vagina. A piece of cotton, a brush, or a small wooden stick is used to gently scrape cells from the cervix and vagina. The cells are viewed under a microscope to find out if they are abnormal. Pap test  procedure is also called a pap smear.

Human Papillomavirus (HPV) Test: A laboratory test used to check DNA or RNA for certain types of HPV  infection. Cells are collected from the cervix and DNA or RNA from the cells is checked to find out if an infection is caused by a type of HPV that is linked to vaginal cancer.

Biopsy: If abnormal cells are found in a Pap test, the doctor may do a biopsy. A sample of tissue is cut from the cervix and viewed under a microscope by a pathologist to check for signs of cancer. A biopsy that removes only a small amount of tissue is usually done in the doctor’s office.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

8th Blood Cancer Conference June 26-27, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA; 18th  World Conference on Lung Cancer October 15 - 18 2017; Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;

Track 15: Cancer Pharmacology

Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

Preventive oncology  July 20-21, 2017 Chicago, USA; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 18th  World Conference on Lung Cancer October 15 - 18 2017 | Yokohama, Japan; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;  Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA;

Track 16Oncology Nursing and Primary care

With the current challenges in the healthcare system, patients and professionals are uncertain about the role, responsibilities, and communication patterns of primary care professionals during cancer care. Oncology and primary care nurses should be surveyed to attain current and preferred roles in cancer care across the care continuum. Who coordinates the care, which makes the referrals, who manages the comorbidities? What is the optimal interface between oncology and primary care nurses in care delivery? How does the environment of care support or impede bidirectional communication among providers and with the patient? We need to test interventions to determine what model produces the best patient-centered outcomes, the best coordinated care. We need to document that coordinated care improves outcomes.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; 19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 18th  World Conference on Lung Cancer October 15 - 18 2017 | Yokohama, Japan; Preventive oncology  July 20-21, 2017 Chicago, USA ; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;  Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA;

Track 17:  Gynecologic Cancer: Case Report

Gynecologic Cancer  case reports play a crucial role in moving new treatments to patients who need those most, securing data so regulatory approvals can be obtained and new drugs can move into widespread clinical practice. Oncology Aesthetics is the practice of safe and beneficial spa services by individuals trained to understand how cervical cancer and associated medical treatments affect the body. Gynecologic Oncology nutrition includes the current therapies used to treat the cancer and nutrition related side effects. Patients who participate in clinical trials provide an invaluable service both to treatment science and fellow patients.

Related Women Cancer ConferencesGynecology Cancer Conferences |Oncology Conferences

19th World Cancer Conference, November 21-23, 2017 London, UK; Annual Scientific Meeting of the British Gynaecological Cancer Society, 15-16 June 2017 Glasgow, UK; 8th Blood Cancer Conference June 26-27, 2017 London, UK; 3rd Urologic Oncology Conference June 26-28, 2017 Baltimore; 2nd Cancer Diagnostics Conference May 8-10, 2017 Barcelona, Spain; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 18th  World Conference on Lung Cancer October 15 - 18 2017 | Yokohama, Japan; 9th Cancer Biomarkers Conference August 23-24, 2017 Birmingham, UK; Preventive oncology  July 20-21, 2017 Chicago, USA ; European Lung Cancer Conference, May 5-8,2017,Switzerland;Gastrointestinal Cancer Conference, October 16-18, 2017 Baltimore, USA; Breast Cancer Conference, October 16-18, 2017 San Francisco, USA; ESMO 2017 Congress, September 8-12, 2017, Spain;  Gynecologic Oncology Congress, July 20-21, 2017 Chicago, USA;

 





Market Analysis

Summary

Gynecologic Cancer is the field of medicine that focuses on cancers of the female generative system. As experts they have wide training in the diagnosis and treatment of this cancer.

In 2012, there were about 4.7 million cases of women cancer worldwide in which 54% cases arose in less developed countries. Although the occurrence and mortality from Gynecologic cancer are major, other cancers are very uncommon.

Gynecologic Cancers Statistics

In the world about 350,000 women are identified with Gynecologic Cancer each year. In 2013, an expected 91,730 were diagnosed. An estimated 170,000 new cases of Gynecologic Cancer were expected to be diagnosed in 2016 in the Europe, and over 70,000 females will lose their battle with this deadly disease. In addition to imposing a significant load on patients and their relations, Gynecologic Cancer places a major burden on the health care organization. Every woman is at risk for emerging a Gynecologic Cancer. It is expected that there will be about 200,000 new cases diagnosed and around 90,000 deaths from Gynecologic Cancer in the UK during 2017.

 
Scope and Importance of Gynecologic Cancer Research

Gynecologic Cancer is the third most commonly diagnosed cancer and the leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Early detection of tumour biology and treatment of Gynecologic Cancer in younger women is more as compared to older women. Effort was devoted to the type of problems met in conducting the analyses and, where data were inadequate, recommending research guidelines or approaches.

Physicians are also involved in leading-edge programs in the prevention of cervical and Gynecologic Cancer through regular screenings and the identification of precancerous cervical lesions associated with papilloma virus infections.Organized screening procedures can support to detect Gynecologic Cancer

A pap smear can identify Gynecologic Cancer. It is suggested to begin analysis every three years early at age 21.

1.     A pelvic exam images the rectum, vagina, cervix, fallopian tubes, uterus, ovaries, and Pelvic tests should be done annually, beginning at 21 and can help detect irregularities of the female reproductive system.

2.     An endometrial tissue sample checks for abnormal cells or signs of uterine cancer which can be done for women with a high risk for endometrial cancer due to an inborn susceptibility or when there are symptoms that need to be evaluated.

Members Associated Gynecologic Cancer Research

Gynecologic Cancer research associated members in UK are about 100000, in Europe about 350000 members and worldwide about 550000 research members. Major Gynecologic Cancer associated hospitals in UK are around 5% when compared to worldwide.

Hospitals in UK

•          The London Clinic

•          Teenage Cancer Trust

•          St Thomas' Hospital

•          London Bridge Digestion Clinic

•          Macmillan Cancer Support

•          NHS Trust Hospital

Hospitals in Europe

  •         Johns Hopkins Hospitals
  •         European Competence Center for Ovarian Cancer
  •         European institute of oncology
  •         University Medical Center Freiburg
  •         Institute Gustave Roussy, Europe
  •         Interdisciplinary Intestinal Tumor Center
  •         University Hospitals of Geneva
  •         Royal Berkshire NHS Foundation Trust
  •         Guy's and St Thomas' Hospital NHS
  •         University Hospital Dusseldorf
  •         NHS Fife

Hospitals worldwide

  •         Georgetown Lombardi Comprehensive Cancer Center Northwest, Washington
  •         Institute Gustave Roussy Villejuif, France
  •         M.D. Anderson Cancer Center, United States
  •         Dana Cancer Center
  •         Abramson Cancer Center Philadelphia, United States
  •         Nuffield Health Bristol Hospital, UK
  •         St. James’ Institute of Oncology, UK
  •         Mercy San Juan Medical Center, California
  •         Fortis Memorial Research Institute, India
  •         El Camino Hospital, California
  •         Johns Hopkins Hospital

 

Societies and associations Associated with Gynecologic Cancer Research

In world there are about 9,685 societies which are specifically associated with Gynecologic Cancer, in which 1289 societies are from Europe and the remaining 269 societies are from London.

Association in UK

  •     Jo’s Cervical Cancer Trust Forum
  •      Macmillan Cancer Support
  •      National Cancer Institute
  •      British Gynaecological Cancer Society
  •      Cancer Research UK
  •      UK Oncology Nursing Society
  •      The British Society for Gynaecological Endoscopy
  •      British Undergraduate Society of Obstetrics and Gynaecology                

  Association in Europe

  •        British Gynaecological Cancer Societies
  •        European Society of Gynaecological Oncology
  •        International Gynecologic Cancer Society
  •        European Network of Gynaecological Oncological Trial groups
  •        Italian Society of Gynecology and Obstetrics
  •        Europe European Network of Cancer Registries
  •        Europe European Oncology Nursing Society EONS
  •        Gynecological Cancer Group
  •         Europe European Breast Cancer Coalition
  •         EORTC Gynecologic Oncology            
  •         The European Consortium for Cervical Cancer Education

Association in Worldwide

  •         American Gynaecological & Obstetrical Society
  •         International Society of Ultrasound in Obstetrics and Gynecology
  •         Nordic Federation of Societies of Obstetrics and Gynecology
  •         International Society of Psychosomatic Obstetrics and Gynaecology
  •         New York Gynecological Society
  •         The international Society of Gynecology and Endoscopy
  •         Breast Cancer Society of Canada
  •         American Cancer Society
  •         Association of Cancer Physicians
  •         Association of Oncology Social Work
  •         Australian Cervical Cancer Foundation

        

Universities Associated with Gynecologic Cancer Research

Universities in UK

  •         Imperial College London
  •         University College London
  •         King’s College London
  •         Queen Mary University of London
  •         Manchester University
  •         University of Glasgow
  •         Imperial College London
  •         University of Birmingham
  •         Kingston University London
  •         University of Cambridge
  •         Institute of Cancer Research
  •         Birkbeck, University of London

 Universities in Europe

  •           University of Cambridge
  •           University of Edinburgh
  •           University of Manchester
  •           University of Oxford
  •           Heidelberg University
  •           University of Amsterdam
  •           Swiss Federal Institute of Technology Zurich
  •           Wageningen University and Research Center
  •           University of Bristol
  •           Aarhus University
  •           University of Copenhagen

Universities in Worldwide

•          Harvard University

•          University of Cambridge

•          Massachusetts Institute of Technology

•          Johns Hopkins University

•          Stanford University

•          University of California, San Francisco

•          Yale University

•          University of California, Los Angeles

•          Texas A & M University

•          Princeton University

•          Cornell University

•          Emory University

•          Stanford University

      

Industries Associated with Gynecologic Cancers Research

Industries associated with Gynecologic Cancer over all the world is about 80% in which 14% of industries are in UK and in London about 6%.

·        Johnson & Johnson

·        Novartis

·        Roche

·        Pfizer

·        Sanofi

·        Merck

·        Bristol-myers squibb

·        Eli Lilly

·        Celgene

·        Takeda

·        AstraZeneca

·        Merck & Co.

·        Bayer

·        Amgen Celgene

·        Otsuka

·        Pharmacyclics

·        Incyte

Market Value on Gynecologic Cancer Research

The global Gynecologic Cancer market in 2010 was valued at $54bn, an increase of 5.1% over the previous year‘s sales of $51.3bn, and is forecasted to grow at a CAGR of 6.9% from 2010–16, reaching $81bn in 2016.

·      Collectively, the seven major markets (US, 5EU, and Japan) represented 79.1% (or $43bn) of in the global cancer market in 2010. In terms of size, the US dominated the global cancer market, with 2010 sales of $21bn and a market share of 38.5%.

·      The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector. Collectively, the leading 10 brands accounted for almost 58.2% (or $31.4bn) of the global cancer market in 2010.

·      In 2010 antineoplastics was the leading drug class in the global cancer market. The global antineoplastic market was valued at $46bn in 2010 at a year-on-year (Y-o-Y) growth of 7.3%. The major drugs that contributed to the 2010 sales in the antineoplastic category were Roche‘s Avastin (bevacizumab) at $6.2bn, Herceptin (trastuzumab) at $5.2bn, and MabThera (rituximab) at $5.1bn, with Y-o-Y sales growth of 3.8%, 3.1%, and 3.3% respectively.

·      The cytostatic hormonal market registered 2010 sales of $8bn at a Y-o-Y decline of 6.5%. AstraZeneca‘s Arimidex (anastrozole) and Novartis‘s Femara (letrozole) led this class, reaching sales of $1.5bn and $1.3bn respectively in 2010.

   

Market Growth of Gynecologic Cancer Research in the last and upcoming ten years

Tech Navio's analysts forecast the Global Gynecologic Cancer market to grow at a CAGR of 12.47% over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of Gynecologic Cancer. The Global Gynecologic Cancer market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market. In next ten years as population ages, the number of people diagnosed with cancer is expected to be double. The volume of cancer services continues to grow. Radiation therapy by 3%,infusion therapy by 7%;Gynecologic services by 10%(annually).With earlier detection, cancer patients will be identified earlier with improvements in chemotherapy, patients will be able to tolerate more treatments, all of which will result in more treatments per patient and more lives saved.

Products manufactured by the industry related Gynecologic

Cancer Research

Market Value:

·        Neosar (Cyclophosphamide)- manufactured by Roxane Laboratories Inc and the market value is 17.06$

·        Paraplat (Carboplatin)-manufactured by Bristol-Myers Squibb Company and the market value is128$

·        Platinol (Cisplatin)-manufactured by Bristol-Myers Squibb Company and the market value is15.3$

·        Gemzar (Gemcitabine Hydrochloride)-manufactured by Eli Lilly and Company and the market value                     is 26.1$

·        Clafen (Cyclophosphamide)-manufactured by Selleckchem and the market value is150$

 

 

 

 

 

 





Past Conference Report

Gynecologic Cancer 2016

The success of the Gynecology & Obstetrics conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “Experts Meeting on Gynecologic Cancer” during October 17-18, 2016 at Rome, Italy Holiday inn Hotel The conference was focused on Gynecologic Cancers Research studies with the theme “Integrating prevention, laboratory research and clinical trials to combat gynecologic cancer”. The meeting occupied a area of comprehensive discussions on different topics like ovarian cancer, Breast cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Alex Ferenczy, McGill University, Canada
  • Jianyu Rao, University of California, USA
  • Franco Maria Buonaguro, Istituto Nazionale Tumori, Italy
  • Giles S L Davies, Kingston University, UK

Conferenceseries LLC offers its heartfelt appreciation to Management Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Gynecologic Cancer 2016, Conferenceseries LLC would like to announce the commencement of the “4th Gynecologic Cancer Conference” to be held during September 05-06, 2017 London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gyneocology Research.

For More details: http://gynecologiccancer.conferenceseries.com/

Let us meet again @ Gynecologic Cancer 2017


Past Reports  Gallery  



Past Conference Report

Gynecologic Oncology 2016

The success of the Gynecology & Obstetrics conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “Experts Meeting on Gynecologic Oncology” during May 19-21, 2016 at Hilton San Antonio Airport Hotel, San Antonio, USA,

The conference was focused on Gynecologic Cancers and Breast cancer Research studies with the theme “Integrating the Milestones in Gynecologic Oncology Globally”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like ovarian cancer, Breast cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Dr. Sandra S. Hatch, The University of Texas Medical Branch, USA
  • Dr. Sherry Bradford, AccuTheranostics, Inc, USA
  • Dr. Hirendranath Banerjee, Elizabeth City State University, USA
  • Dr. Karl Reinhard Aigner, Medias Klinikum GmbH & Co KG, Germany
  • Mr. Adrian Senderowicz, CeruleanPharma, Inc., USA
  • Dr. Magdalena Klink, Polish Academy of Sciences, Poland

Best Poster Awardees:

Sean S. Jacob: University of Central Florida, USA

Alexis Barfield: USA

Dorothy Crumity: USA

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Gynecologic Oncology 2016, Conferenceseries LLC would like to announce the commencement of the “3rd World Gynecologic Oncology Congress” to be held during July 20-21, 2017 Chicago, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gyneocology Research.

For More details: http://gynecologic-oncology.conferenceseries.com/

Let us meet again @ Gynecologic Oncology 2017


Past Reports  Gallery  



Past Conference Report

Cancer Science-2014

OMICS Group’s 4th World Congress on Cancer Science & Therapy was held during October 20-22, 2014 at DoubleTree by Hilton Hotel Chicago - North Shore Conference Center, Chicago, USA.

Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, leaders from the fields of Cancer Therapy, and students from diverse groups, who made this conference one of the most successful and productive events in 2014 from OMICS Group.

The conference proceedings were carried out through effectual keynote lectures by:

Dr. Peter Weightman, University of Liverpool, UK
Dr. Sudhakar Akul YakkantiSRI International, USA
Dr. Jeffrey B. Ulmer, Novartis Vaccines & Diagnostics, USA
Dr. Reza Hakkak, University of Arkansas for Medical Sciences, USA

This annual conference brought together eminent experts from different countries in which many modern issues were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided a good platform to share their ideas and experiences in the field of cancer therapy.

The conference was greeted by the welcome message by our moderators Juan Jose Marugan, National Institutes of Health, USA and Bernard Friedenson, University of Illinois, USA, and welcomed Honorable guests Sudhakar Akul Yakkanti, SRI International, USA, Anupam Bishayee, California Northstate University, USA, and Reza HakkakUniversity of Arkansas for Medical Sciences, USA.

We sincerely acknowledge all the organizing committee members, moderators, chair and co-chairs, editorial board members, speakers, delegates for their gracious presence, and support in making this event successful. OMICS Group has taken the privilege of felicitating Cancer Science-2014 Organizing Committee Members, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2014. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Enhanced diagnosis, treatment and management of different cancers”, the speakers recommended organizing the conference in the field of Cancer Science and Therapy in the coming years also.

We are obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2014. With the unique feedback from the conference, OMICS Group would like to announce its "5th World Congress on Cancer Science & Therapy" to be held during October 20-22, 2014 in Chicago, USA.


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date Aug 28-29, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations